ClinicalTrials.gov
public full text
Public Domain
Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)
The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fasting condition and at least 28 days washout period between the doses.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator#148731
- Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg#252963
- 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting#311091
- Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg#363587
- Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery#918827
Record · ID 844842
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive